OMS721 100 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody

( DrugBank: - / KEGG DRUG: - )


2 diseases
IDDisease name (Link within this page)Number of trials
64Thrombotic thrombocytopenic purpura4
IDDisease name (Link within this page)Number of trials
109Atypical hemolytic uremic syndrome4

64. Thrombotic thrombocytopenic purpura


Clinical trials : 114 / Drugs : 119 - (DrugBank : 17) / Drug target genes : 16 - Drug target pathways : 63 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

109. Atypical hemolytic uremic syndrome


Clinical trials : 130 / Drugs : 44 - (DrugBank : 5) / Drug target genes : 2 - Drug target pathways : 11 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries